|Revised international prognostic scoring system for myelodysplastic syndromes|
PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ...
Blood 120 (12), 2454-2465, 2012
|Clinical and biological implications of driver mutations in myelodysplastic syndromes|
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3616-3627, 2013
|Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.|
L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ...
Journal of clinical oncology 25 (23), 3503-3510, 2007
|Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts|
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
|Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making|
L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ...
Journal of Clinical Oncology 23 (30), 7594-7603, 2005
|Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet|
L Malcovati, E Hellström-Lindberg, D Bowen, L Adès, J Cermak, ...
Blood 122 (17), 2943-2964, 2013
|CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure|
M Valgimigli, GM Rigolin, A Fucili, MD Porta, O Soukhomovskaia, ...
Circulation 110 (10), 1209-1212, 2004
|Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms|
L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ...
Blood, The Journal of the American Society of Hematology 118 (24), 6239-6246, 2011
|Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome|
M Jadersten, L Malcovati, I Dybedal, M Giovanni Della Porta, R Invernizzi, ...
Journal of Clinical Oncology 26 (21), 3607-3613, 2008
|Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative …|
F Passamonti, E Rumi, D Pietra, MGD Porta, E Boveri, C Pascutto, ...
Blood 107 (9), 3676-3682, 2006
|Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study|
J Porter, R Galanello, G Saglio, EJ Neufeld, E Vichinsky, MD Cappellini, ...
European journal of haematology 80 (2), 168-176, 2008
|The genetic basis of myelodysplasia and its clinical relevance|
M Cazzola, MG Della Porta, L Malcovati
Blood, The Journal of the American Society of Hematology 122 (25), 4021-4034, 2013
|Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile|
M Valgimigli, GM Rigolin, C Cittanti, P Malagutti, S Curello, G Percoco, ...
European heart journal 26 (18), 1838-1845, 2005
|Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia|
J Boultwood, J Perry, A Pellagatti, M Fernandez-Mercado, ...
Leukemia 24 (5), 1062-1065, 2010
|Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)|
L Malcovati, MG Della Porta, C Strupp, I Ambaglio, A Kuendgen, ...
Haematologica 96 (10), 1433-1440, 2011
|Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes|
MG Della Porta, L Malcovati, E Boveri, E Travaglino, D Pietra, C Pascutto, ...
Journal of clinical oncology 27 (5), 754-762, 2009
|SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts|
L Malcovati, M Karimi, E Papaemmanuil, I Ambaglio, M Jädersten, ...
Blood, The Journal of the American Society of Hematology 126 (2), 233-241, 2015
|Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes|
AA Van De Loosdrecht, C Alhan, MC Béné, MG Della Porta, AM Dräger, ...
haematologica 94 (8), 1124-1134, 2009
|Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome|
MG Della Porta, L Malcovati, C Strupp, I Ambaglio, A Kuendgen, ...
haematologica 96 (3), 441-449, 2011
|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|
PS Woll, U Kjällquist, O Chowdhury, H Doolittle, DC Wedge, S Thongjuea, ...
Cancer cell 25 (6), 794-808, 2014